Astragaloside IV alleviates heart failure via activating PPARα to switch glycolysis to fatty acid β-oxidation
Abstract In heart failure (HF), energy metabolism pathway in cardiac muscle changes from fatty acid β-oxidation to glycolysis. However, the exact mechanism is unknown. Sarcoendoplasmic reticulum Ca2+α ATPase (SERCA) expression is downregulated and mitochondrial function is reduced in HF, perhaps par...
Enregistré dans:
Auteurs principaux: | Zhiwei Dong, Pei Zhao, Ming Xu, Chen Zhang, Wei Guo, Huihua Chen, Jing Tian, Hongchang Wei, Rong lu, Tongtong Cao |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f6c1867536f84fb8b650e16dd272b5e3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Astragaloside IV alleviates heart failure by promoting angiogenesis through the JAK-STAT3 pathway
par: Yan-Bo Sui, et autres
Publié: (2019) -
Astragaloside IV Alleviates Liver Inflammation, Oxidative Stress and Apoptosis to Protect Against Experimental Non-Alcoholic Fatty Liver Disease
par: Liang XY, et autres
Publié: (2021) -
Effects of astragaloside IV on the pharmacokinetics of omeprazole in rats
par: Wei Liu, et autres
Publié: (2019) -
Research Progress on the Ability of Astragaloside IV to Protect the Brain Against Ischemia-Reperfusion Injury
par: Xianhui Kang, et autres
Publié: (2021) -
Bistability in glycolysis pathway as a physiological switch in energy metabolism.
par: Bhanu Chandra Mulukutla, et autres
Publié: (2014)